795 A multicenter phase II trial (SWOG S1609, cohort 51) of ipilimumab and nivolumab in metastatic or unresectable angiosarcoma: a substudy of dual anti-CTLA-4 and anti-PD-1 blockade in rare tumors (DART)

Authors :: Michael Wagner
Howard Streicher
Elad Sharon
Razelle Kurzrock
Young Kwang Chae
Megan Othus
Sandip Patel
Edward Mayerson
Christopher Ryan
Melissa Plets
Charles Blanke
Ashish Sangal
Benjamin Powers
George Budd
Adrienne Victor
Chung-Tsen Hsueh
Rashmi Chugh
Suresh Nair
Kirsten Leu
Mark Agulnik
Source :: Journal for ImmunoTherapy of Cancer, Vol 8, Iss Suppl 3 (2020)
Publication Year :: 2020
Publisher :: BMJ Publishing Group, 2020.

Subjects :: Neoplasms. Tumors. Oncology. Including cancer and carcinogens
RC254-282

Full Text Access

Tools